Pandemic Darlings The pandemic economy, in original documents
Home Source documents Bill Analysis — Senate Bill 257, Medication Cost Transparency Act (May 19, 2021)

Bill Analysis — Senate Bill 257, Medication Cost Transparency Act (May 19, 2021)

Summary

Bill analysis of Senate Bill 257, Medication Cost Transparency Act, for the Senate Commerce and Insurance committee, dated May 19, 2021, prepared by Jason Moran-Bates. It states the bill would require pharmacy benefits managers (PBMs) to be licensed, extend consumer protections, restrict PBMs from prohibiting pharmacies from taking certain actions, and establish rules for claim overpayments and PBM networks. The initial application fee for licensure would be $2,000, and annual renewal fees would be $1,500. The bill would increase the Commissioner's ability to take enforcement action against PBMs. The bill would be effective October 1, 2021, and apply to contracts entered into, renewed, or amended on or after that date.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Bill Analysis — Senate Bill 257, Medication Cost Transparency Act (May 19, 2021).” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2021-05-20-s257-smbc-107-e1-v1-b231e75e20/, SHA-256 8b3e71727439e973c1bdc341e0bbe1964bd9b741bacd8fb5c3dc54440bd91dd2.

Full text

                                                     SENATE BILL 257:
                                                     Medication Cost Transparency Act.
      2021-2022 General Assembly
     Committee:     Senate Commerce and Insurance. If favorable, Date:          May 19, 2021
                    re-refer to Rules and Operations of the Senate
     Introduced by: Sens. Perry, Britt, Johnson                    Prepared by: Jason Moran-Bates
     Analysis of:   First Edition                                               Staff Attorney

     OVERVIEW: Senate Bill 257 would require pharmacy benefits managers (PBMs) to be licensed. It
     would add to the consumer protections in G.S. 58-56A-3, restrict PBMs from prohibiting pharmacies
     from taking certain actions, and establish rules for claim overpayments and PBM networks. It would
     also increase the Commissioner's ability to take enforcement action against PBMs.
     BILL ANALYSIS:
     Section 1.(a) would recodify G.S. 58-56A-10 as G.S. 58-56A-30.
     Section 1.(b) would make several changes, including the addition of new sections, to Article 56A.
            •     G.S. 58-56A-1. Definitions, an existing section, would add new definitions for "claim," "claims
                  processing service," "maximum allowable cost list," "out-of-pocket costs," "pharmacy services
                  administration organization," "pharmacist services," and "pharmacy benefits manager affiliate."
                  The existing definition of "health benefit plan" would be referenced to a different statute, but the
                  State Health Plan would remain excluded from the definition.
            •     G.S. 58-56A-2. Licensure, a new section, would prohibit PBMs from operating without a license.
                  The initial application fee would be $2,000, and annual renewal fees would be $1,500. Applicants
                  would have to provide corporate and financial documents to the Department of Insurance as part
                  of the application process. This section would also establish procedures for the Department to
                  deny license applications.
            •     G.S. 58-56A-3. Consumer protections, an existing section, would be amended to extend its
                  current consumer protection provisions. Under the new language, PBMs could not prohibit
                  pharmacies from charging a shipping and handling fee for mailed prescriptions, as long as the
                  insured is notified about the fee.
             •     G.S. 58-56A-4 Pharmacy and pharmacist protections, an existing section, would be
                   extensively amended. It would:
                          o Prohibit PBMs from charging fees not on the remittance form or agreed to in advance by
                            then pharmacy.
                          o Allow pharmacists to refuse to fill prescriptions if they believed the prescription was not
                            in the patient's best interest, or if there were a question about the validity of the
                            prescription.
                          o PBMs would be prohibited from preventing pharmacies from dispensing any drug,
                            including specialty drugs, and from retaliating against pharmacies.

                                                                                                                                                             Legislative Analysis
     Jeffrey Hudson
                                                                                                                                                                   Division
         Director                                         S257-SMBC-107(e1)-v-1                                                                                919-733-2578
This bill analysis was prepared by the nonpartisan legislative staff for the use of legislators in their deliberations and does not constitute an official statement of legislative intent.
Senate Bill 257
Page 2

             o Retroactive denials or reductions of paid claims would be prohibited in most
               circumstances.
             o PBMs would retain the right to recover overpayments.
    •    G.S. 58-56A-5. Maximum allowable cost price, an existing section, would be amended to
         prohibit PBMs from including dispensing fees in the maximum allowable cost price. PBMs would
         also be required to establish a procedure for pharmacies to appeal PBMs' reimbursement
         decisions.
    •    G.S. 58-56A-15. Pharmacy benefits manager networks, a new section, would create new rules
         for PBM networks.
            o All network pharmacies must be able to participate on the same terms, without benefit
              differentials.
            o Pharmacies that are members of pharmacy service administration organizations that enter
              into contracts with PBMs would be entitled to receive a copy of the contract provisions
              applicable to the pharmacy.
            o Payments due a pharmacy must be paid even if the pharmacy is terminated from the
              network.
    •    G.S. 58-56A-20. Pharmacy benefits manager affiliate disclosure; sharing of data, a new
         section, would prevent PBMs from sharing information in a manner that violated HIPAA.
    •    G.S. 58-56A-25. Enforcement, a new section, would allow the Commissioner to examine the
         affairs of any PBM. The Commissioner could retain the professionals necessary to conduct the
         exam, and PBMs would bear the cost of the examinations. None of the information disclosed
         during the examination would be a public record under Chapter 132. Violations of Article 56A
         would be subject to penalties, including revocation of licensure.
    •    G.S. 58-56A-30. Civil Penalties for violations; administrative procedure, an existing section,
         would be amended to allow the Commissioner to petition a court to compel a PBM to pay
         restitution to (i) pharmacies harmed by the PBM's violation of Article 56A or (ii) the Department
         of Insurance.
    •    G.S. 58-56A-45. Rules, a new section, would give the Commission the power to adopt rules
         necessary to implement the provisions of Article 56A.
Sections 2 and 3 of the bill would make conforming changes to G.S. 58-2-40 (the powers of the
Commissioner of Insurance) and G.S. 58-56-2 (third party administrator definitions), respectively.
EFFECTIVE DATE: The bill would be effective October 1, 2021, and apply to contracts entered into,
renewed, or amended on or after that date.
*Amy Darden, Staff Attorney, substantially contributed to this summary.


File and source

File
2021-05-20_S257-SMBC-107-e1-v1.pdf
Size
75,275 bytes
SHA-256
8b3e71727439e973c1bdc341e0bbe1964bd9b741bacd8fb5c3dc54440bd91dd2
Our copy
2021-05-20_S257-SMBC-107-e1-v1.pdf
Original
No public link identified.
Back to top